Cough, Cold and Allergy (Hay Fever) Remedies in Indonesia
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN INDONESIA
Euromonitor International
January 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Herbal Ingredients Drive Sales of Combination Products
Opportunities Within Decongestant Rubs
Promising Outlook for Cough, Cold, and Allergy (hay Fever) Remedies
Competitive Landscape
Deltomed Laboratories Leads Sales
Local Brands Perform Well in 2018
Internet Retailing Beginning To Emerge
Category Data
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018
Table 3 Sales of Decongestants by Category: Value 2013-2018
Table 4 Sales of Decongestants by Category: % Value Growth 2013-2018
Table 5 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018
Table 6 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018
Table 7 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023
Table 8 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023
Executive Summary
Consumer Health Sales Continue To Rise
Herbal/traditional Products Drive Growth
International Brands Dominate Sales
Emergence of Internet Retailing for Consumer Health Products
Promising Outlook for Consumer Health
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 10 Life Expectancy at Birth 2013-2018
Market Data
Table 11 Sales of Consumer Health by Category: Value 2013-2018
Table 12 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 13 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 14 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 15 Distribution of Consumer Health by Format: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format and Category: % Value 2018
Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Definitions
Sources
Summary 1 Research Sources
Combination products within cough, cold, and allergy (hay fever) continue to perform better than in 2017. Many brands within this area have been available for decades. Tolak Angin and Antangin are the leading cough, cold, and allergy (hay fever) products, offering herbal ingredients such as cardamom, ginger and clove. Indonesian consumers believe that herbal brands are healthier than regular medications, with such products consequently leading sales. Furthermore, such products claim to cure cold...
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Indonesia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.